The Charles Bonnet syndrome (CBS) treatment landscape — addressing complex visual hallucinations that occur in people with significant vision loss who retain full insight that the images they see aren't real — remains one of the more striking gaps in neuro-ophthalmic care, with the Charles Bonnet Syndrome Market reflecting a clinical landscape where, despite the condition affecting...